Duration effective levels of three antitumor drugs in mice with leukemia L1210 implanted intracerebrally and subcutaneously.

Duration effective levels of three antitumor drugs in mice with leukemia L1210 implanted intracerebrally and subcutaneously. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Duration effective levels of three antitumor drugs in mice with leukemia L1210 implanted intracerebrally and subcutaneously. Abstract Text:

M A Chirigos,S R Humphreys,A Goldin,

Duration effective levels of three antitumor drugs in mice with leukemia L1210 implanted intracerebrally and subcutaneously. Publishing Authors By Initials

MA Chirigos,SR Humphreys,A Goldin,

For similar animals: chordata: vertebrates: mammals: rodentia: muridae: murinae: mice research abstracts see: animals: chordata: vertebrates: mammals: rodentia: muridae: murinae: mice research

PUBMED ID PMID:

MEDLINE DATE:

Duration effective levels of three antitumor drugs in mice with leukemia L1210 implanted intracerebrally and subcutaneously. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer chemotherapy reports. Part 1

VOLUME: 49

Page Numbers: 15-9

Journal Abbreviation:

ISSN: 0069-0112

DAY: 20

MONTH: Dec

YEAR: 1965

Duration effective levels of three antitumor drugs in mice with leukemia L1210 implanted intracerebrally and subcutaneously. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7607105

Duration effective levels of three antitumor drugs in mice with leukemia L1210 implanted intracerebrally and subcutaneously. Keywords Mesh Terms:

KEYWORDS: Mice

MESH TERMS: drug therapy

Chemical & Substance for Abstract: Duration effective levels of three antitumor drugs in mice with leukemia L1210 implanted intracerebrally and subcutaneously. Information

Substance Name: Antineoplastic Agents

Registry Number: 0

Grant and Affiliation Information for Duration effective levels of three antitumor drugs in mice with leukemia L1210 implanted intracerebrally and subcutaneously.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Chemother Rep

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Duration effective levels of three antitumor drugs in mice with leukemia L1210 implanted intracerebrally and subcutaneously Related Publications

• 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and methotrexate (NSC-740) as combination therapy for advanced mouse leukemia L1210.
• Antileukemic action of a new sugar derivative dimethanesulfonate (NSC-122402) and related compounds in mice.
• Cancer chemotherapy; analysis of results of different screening techniques with nitrogen-mustard analogues.
• Cell-mediated response to a mouse leukemic subline antigenically altered following drug treatment in vivo.
• Chemotherapeutic response of epithelial tumors produced by primary implantation of a nonproducer line of murine sarcoma virus-transformed BALB 3T3 cells.
• Comparison of the antileukemic effect in mice of adriamycin (NSC-123127) with daunomycin (NSC-82151).
• Criteria for selection of new analogs of antitumor antibiotics.
• Duration effective levels of three antitumor drugs in mice with leukemia L1210 implanted intracerebrally and subcutaneously.
• Effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and cyclophosphamide (NSC-26271) on nicotinamide adenine dinucleotide glycohydrolase in normal and leukemic mouse tissues.
• Effect of day of dosage omission on survival time in the regularly scheduled methotrexate (NSC-740) treatment of leukemia L1210.
• Effect of frozen storage on the response to therapy of drug-resistant transplantable mouse tumors.
• Effectiveness of daunomycin (NSC-82151) against experimental tumors.
• Effects of levamisole (NSC-177023) and tetramisole (NSC-102063) in experimental tumor systems.
• Evaluation of surgery and chemotherapy in the treatment of mouse mammary adenocarcinoma 755.
• Genomic abnormalities of the murine model of Fabry disease after disease-related perturbation, a systems biology approach.
• High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis.
• Increased immunogenicity of murine lymphatic tumors by pyrazole-4-carboxamide, 3(or 5)-amino (NSC-1402; PCA).
• Increased lifespan using the priming dose schedule design in carbazilquinone (NSC-134679) treatment of mouse leukemia L1210.
• Influence of mitotic cycle inhibitors on the antileukemic activity of cytosine arabinoside (NSC-63878) in mice bearing leukemia L1210.
• Influence of route of administration on antileukemic activity of cytosine arabinoside (NSC-63878) in advanced leukemia L1210 in mice.
• Influence of treatment schedules and route of administration on the chemotherapy of murine leukemia L1210 with 5(or 4)-[3,3-bis( 2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196).
• Paracolon endocarditis.
• Prevention of cyclophosphamide (NSC-26271) immunosuppression by bacillus Calmette-Guérin.
• Relationship between white blood cell count and diagnosis and therapeutic response in AKR mice with spontaneous leukemia (lymphoma).
• Semliki Forest virus vectors with mutations in the nonstructural protein 2 gene permit extended superinfection of neuronal and non-neuronal cells.
• Studies on therapeutic effectiveness of drugs with tumor weight and survival time indices of Walker 256 carcinosarcoma.
• The effect of folic-acid derivatives on sarcoma 180.
• The effect of restraint stress on the normal colon and on intestinal inflammation in a model of experimental colitis.
• Use of first generation transplants of a slow growing solid tumor for the evaluation of new cancer chemotherapeutic agents.
• [Electronic microscopy in the study of the structure of the brain.]